BB BIOTECH AG 13D and 13G filings for Ionis Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 8:34 pm Sale | 2024-09-30 | 13G | Ionis Pharmaceuticals, Inc. IONS | BB BIOTECH AG | 7,850,000 5.000% | -740,000 (-8.61%) | Filing |
| 2024-02-13 06:09 am Sale | 2023-12-31 | 13G | Ionis Pharmaceuticals, Inc. IONS | BB BIOTECH AG | 8,590,000 6.000% | -1,045,000 (-10.85%) | Filing |
| 2023-02-14 4:07 pm Sale | 2022-12-31 | 13G | Ionis Pharmaceuticals, Inc. IONS | BB BIOTECH AG | 9,635,000 6.800% | -597,973 (-5.84%) | Filing |
| 2022-02-11 4:42 pm Purchase | 2021-12-31 | 13G | Ionis Pharmaceuticals, Inc. IONS | BB BIOTECH AG | 10,232,973 7.200% | 2,012,973 (+24.49%) | Filing |
| 2021-02-12 4:07 pm Purchase | 2020-12-31 | 13G | Ionis Pharmaceuticals, Inc. IONS | BB BIOTECH AG | 8,220,000 5.900% | 225,045 (+2.81%) | Filing |